company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:11:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3997000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:11:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3997000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:11:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3997000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:11:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4733000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:11:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6931000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:11:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11664000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:11:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7667000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:11:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-8989000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:11:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8989000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:11:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16656000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:11:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16656000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:11:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16656000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:11:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16656000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:11:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,110383000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:11:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:11:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,110383000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:11:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:11:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,111000000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 17:11:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:31:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8702000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:31:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8702000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:31:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8702000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:31:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3440000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:31:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9059000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:31:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12499000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:31:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3797000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:31:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3496000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:31:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3496000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:31:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7293000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:31:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7293000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:31:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7293000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:31:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7293000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:31:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,104200000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:31:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:31:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,104200000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:31:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:31:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,111767000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2010.0,Q3,2010-07-01,2010-09-30,2011-11-08 16:31:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 09:01:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14296000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 09:01:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14296000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 09:01:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14296000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 09:01:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5026000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 09:01:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14801000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 09:01:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19827000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 09:01:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5531000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 09:01:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 09:01:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7364000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 09:01:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7364000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 09:01:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1833000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 09:01:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1833000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 09:01:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1833000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 09:01:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1833000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 09:01:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,112482000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 09:01:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.02
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 09:01:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,121285000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 09:01:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.02
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 09:01:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,91700000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 09:01:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.02
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 16:13:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11585000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 16:13:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11585000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 16:13:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11585000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 16:13:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3960000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 16:13:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17750000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 16:13:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21710000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 16:13:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10125000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 16:13:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 16:13:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11404000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 16:13:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,11404000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 16:13:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1279000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 16:13:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1279000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 16:13:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1279000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 16:13:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1279000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 16:13:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,22348000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 16:13:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.06
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 16:13:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23153000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 16:13:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.06
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 16:13:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21300000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q2,2011-04-01,2011-06-30,2012-08-07 16:13:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.06
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:29:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7524000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:29:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7524000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:29:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7524000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:29:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3185000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:29:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15610000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:29:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18795000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:29:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11271000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:29:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:29:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7251000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:29:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7251000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:29:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4020000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:29:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4020000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:29:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4020000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:29:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4020000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:29:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,22623000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:29:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:29:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,22623000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:29:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:29:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,22623000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q3,2011-07-01,2011-09-30,2012-11-07 16:29:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13585000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13585000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13585000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3884000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18701000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22585000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9000000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7590000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7590000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1410000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1410000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1410000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1410000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21599000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21599000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21599000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:21:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11212000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:21:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11212000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:21:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11212000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:21:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3281000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:21:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14805000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:21:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18086000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:21:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6874000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:21:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10830000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:21:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10830000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:21:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17704000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:21:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17704000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:21:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17704000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:21:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17704000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:21:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,22624000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:21:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.78
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:21:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,22624000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:21:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.78
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:21:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,22624000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q1,2012-01-01,2012-03-31,2013-05-09 17:21:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.78
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 07:08:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11207000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 07:08:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11207000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 07:08:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11207000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 07:08:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2915000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 07:08:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13849000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 07:08:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16764000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 07:08:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5557000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 07:08:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,107000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 07:08:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,13488000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 07:08:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,13595000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 07:08:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8038000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 07:08:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8038000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 07:08:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8038000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 07:08:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8038000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 07:08:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,22624000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 07:08:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.36
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 07:08:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23000000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 07:08:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.35
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 07:08:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,22658000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 07:08:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.36
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:01:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7574000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:01:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7574000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:01:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7574000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:01:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3565000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:01:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10914000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:01:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14479000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:01:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6905000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:01:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,67000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:01:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-42716000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:01:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-42649000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:01:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-49554000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:01:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-49554000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:01:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-49554000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:01:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-49554000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:01:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,22824000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:01:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.17
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:01:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,22800000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:01:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.17
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:01:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,22824000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 07:01:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.17
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7336000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7336000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7336000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4869000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12834000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17703000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10367000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-174000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-51526000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-51700000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-62067000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-62067000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-62067000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-62067000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23602000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.63
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23602000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.63
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23602000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.63
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:55:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4474000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:55:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4474000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:55:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4474000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:55:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6127000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:55:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13762000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:55:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19889000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:55:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15415000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:55:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-26669000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:55:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-26669000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:55:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-42084000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:55:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42084000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:55:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42084000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:55:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-42084000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:55:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31813000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:55:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.32
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:55:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31813000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:55:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.32
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:55:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31813000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:55:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.32
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:49:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2951000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:49:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2951000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:49:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2951000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:49:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7054000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:49:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12984000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:49:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20038000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:49:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17087000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:49:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1964000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:49:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1964000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:49:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19051000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:49:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19051000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:49:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19051000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:49:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19051000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:49:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31984000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:49:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.6
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:49:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31984000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:49:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.6
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:49:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31984000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 06:49:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.6
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 06:30:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4168000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 06:30:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4168000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 06:30:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4168000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 06:30:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8014000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 06:30:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21087000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 06:30:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29101000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 06:30:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24933000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 06:30:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-17097000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 06:30:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-17097000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 06:30:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-42030000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 06:30:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42030000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 06:30:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42030000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 06:30:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-42030000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 06:30:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33943000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 06:30:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.24
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 06:30:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33943000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 06:30:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.24
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 06:30:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33943000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 06:30:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.24
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2626000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2626000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2626000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10399000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25076000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35475000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-32849000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,24029000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,24029000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8820000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8820000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8820000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8820000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33850000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33850000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33850000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:02:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6088000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:02:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6088000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:02:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6088000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:02:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10303000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:02:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20906000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:02:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31209000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:02:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25121000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:02:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3152000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:02:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3152000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:02:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28273000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:02:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28273000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:02:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28273000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:02:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28273000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:02:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37821000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:02:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.75
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:02:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37821000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:02:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.75
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:02:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37821000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 07:02:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.75
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:00:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2583000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:00:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2583000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:00:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2583000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:00:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12213000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:00:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20641000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:00:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32854000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:00:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30271000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:00:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3603000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:00:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3603000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:00:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33874000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:00:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33874000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:00:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33874000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:00:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-33874000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:00:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39862000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:00:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.85
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:00:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39862000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:00:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.85
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:00:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39862000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q2,2014-04-01,2014-06-30,2015-08-06 07:00:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.85
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 07:01:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1059000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 07:01:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1059000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 07:01:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1059000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 07:01:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12882000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 07:01:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21852000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 07:01:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34734000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 07:01:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-33675000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 07:01:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4449000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 07:01:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4449000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 07:01:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29226000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 07:01:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29226000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 07:01:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29226000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 07:01:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29226000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 07:01:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41066000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 07:01:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.71
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 07:01:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41066000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 07:01:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.71
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 07:01:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41066000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 07:01:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.71
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13917000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30832000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44749000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-44722000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,306000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,306000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-44416000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-44416000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-44416000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-44416000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40026000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.08
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40026000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.08
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40026000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.08
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 06:46:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,22697000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 06:46:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39165000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 06:46:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,61862000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 06:46:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-61862000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 06:46:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,303000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 06:46:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,303000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 06:46:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-61559000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 06:46:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-61559000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 06:46:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-61559000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 06:46:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-61559000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 06:46:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41324000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 06:46:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.49
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 06:46:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41324000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 06:46:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.49
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 06:46:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41324000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 06:46:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.49
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12927000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29180000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,42107000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-42107000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,256000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,256000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-41851000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41851000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41851000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-41851000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41357000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.01
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41357000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.01
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41357000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:06:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.01
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 08:31:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15090000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 08:31:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36673000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 08:31:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51763000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 08:31:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-51763000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 08:31:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-176000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 08:31:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-176000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 08:31:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-51939000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 08:31:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51939000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 08:31:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-51939000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 08:31:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-51939000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 08:31:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41565000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 08:31:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.25
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 08:31:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41565000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 08:31:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.25
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 08:31:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41565000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q3,2015-07-01,2015-09-30,2016-11-07 08:31:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.25
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1253000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1253000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1253000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24329000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,41376000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,65705000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-64452000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-229000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-229000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-64681000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-64681000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-64681000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-64681000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42290000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.45
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42290000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.45
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42290000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.45
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:02:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,20876000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:02:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38826000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:02:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59702000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:02:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-59702000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:02:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-68000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:02:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-68000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:02:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-59770000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:02:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:02:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59770000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:02:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59770000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:02:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-59770000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:02:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45697000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:02:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.31
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:02:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45697000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:02:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.31
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:02:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45697000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:02:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.31
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:34:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17752000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:34:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,44348000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:34:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62100000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:34:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-62100000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:34:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-201000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:34:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-201000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:34:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-62301000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:34:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:34:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-62301000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:34:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-62301000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:34:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-62301000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:34:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46157000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:34:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.35
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:34:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46157000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:34:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.35
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:34:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46157000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q2,2016-04-01,2016-06-30,2017-08-03 16:34:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.35
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:33:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,22184000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:33:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34349000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:33:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,56533000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:33:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-56533000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:33:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-209000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:33:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-209000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:33:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-56742000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:33:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:33:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-56742000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:33:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-56742000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:33:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-56742000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:33:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48254000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:33:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.18
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:33:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48254000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:33:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.18
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:33:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48254000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q3,2016-07-01,2016-09-30,2017-11-01 16:33:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.18
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5421000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5421000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5421000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,22937000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,70749000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,29000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,101000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,93816000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-88395000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-57000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-57000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-88452000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-88452000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-88452000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-88452000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48697000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.65
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48697000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.65
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48697000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.65
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16342000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16342000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16342000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,26216000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29119000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,29000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,223000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55587000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-39245000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,125335000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,125335000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,86090000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2000000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,84090000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,84090000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,84090000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54850000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.53
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,56012000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.5
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,56012000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q1,2017-01-01,2017-03-31,2018-05-03 16:02:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.53
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,35011000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,35011000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,35011000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,36069000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,58908000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,28000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3345000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,98350000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-63339000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,184000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,184000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-63155000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-109000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-63046000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-63046000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-63046000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54976000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.15
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54976000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.15
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54976000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q2,2017-04-01,2017-06-30,2018-08-08 16:36:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.15
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,45954000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,45954000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,45954000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,28176000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34239000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,780000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,28666000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,91861000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-45907000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,184000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,184000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-45723000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2011000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-47734000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-47734000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-47734000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,61528000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.78
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,61528000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.78
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61528000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q3,2017-07-01,2017-09-30,2018-10-31 16:04:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.78
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,57277000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,57277000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,57277000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,32221000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,44441000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,216000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3546000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,80424000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23147000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2693000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2693000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25840000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1842000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23998000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23998000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23998000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58818000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.46
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,58818000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.43
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58818000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.46
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,64604000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,64604000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,64604000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43341000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,46204000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,216000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,5582000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,95343000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30739000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4485000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4485000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-35224000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,139000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35363000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35363000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-35363000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64631000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.55
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,64631000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.55
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64631000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:02:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.55
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,73529000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,73529000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,73529000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,47156000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,122848000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,217000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,6735000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,176956000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-103427000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5218000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5218000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-108645000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,622000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-109267000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-109267000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-109267000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65484000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.67
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,65484000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.67
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,65484000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:02:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.67
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,78486000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,78486000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,78486000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,53044000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,86584000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,216000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,8741000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,148585000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-70099000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6968000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6968000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-77067000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-674000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-76393000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-76393000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-76393000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,66209000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.15
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66209000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.15
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,66209000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q3,2018-07-01,2018-09-30,2019-11-07 16:03:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.15
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,84415000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,84415000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,84415000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,64220000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,146207000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,216000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,13135000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,223778000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-139363000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2311000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2311000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-141674000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-779000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-140895000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-140895000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-140895000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,66250000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.09
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,66250000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.09
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,66250000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.09
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,87011000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,87011000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,87011000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,60566000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,90553000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,216000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,12063000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,163398000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-76387000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-172000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-172000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-76559000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,84000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-76643000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-76643000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-76643000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71731000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.07
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71731000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.07
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71731000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:02:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.07
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,94668000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,94668000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,94668000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,67393000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,286506000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,217000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,15919000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,370035000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-275367000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-862000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-862000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-276229000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,174000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-276403000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-276403000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-276403000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73958000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.74
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73958000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.74
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73958000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:02:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.74
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,99041000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,99041000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,99041000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,75429000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,133949000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,216000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,13037000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,222631000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-123590000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2510000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2510000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-126100000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,226000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-126326000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-126326000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-126326000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74177000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.7
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74177000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.7
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74177000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q3,2019-07-01,2019-09-30,2019-11-07 16:03:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.7
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,100113000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,100113000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,100113000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,81424000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,223141000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,200000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,25567000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,330332000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-230219000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4773000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4773000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-234992000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,711000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-235703000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-235703000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-235703000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73615000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.2
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73615000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.2
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73615000.0
Sarepta Therapeutics Inc,SRPT,,0000873303,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.2
